Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delphine Denoyer

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Drug Metabolism|March 6, 2002
The multidrug resistance mechanisms and their interactions with the radiopharmaceutical probes used for an in vivo detectionNathalie Perek, Delphine Denoyer
Cancer Biotherapy & Radiopharmaceuticals|August 24, 2005
MRP-1 protein expression and glutathione content of in vitro tumor cell lines derived from human glioma carcinoma U-87-MG do not interact with 99mTc-glucarate uptakeNathalie Perek, Nathalie Le Jeune, Delphine Denoyer, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Influence of glutathione depletion on plasma membrane cholesterol esterification and on Tc-99m-sestamibi and Tc-99m-tetrofosmin uptakes: a comparative study in sensitive U-87-MG and multidrug-resistant MRP1 human glioma cellsNathalie Le Jeune, Nathalie Perek, Delphine Denoyer, et al.
Current Cancer Drug Targets|May 23, 2006
Spectrum of radiopharmaceuticals in nuclear oncologyDelphine Denoyer, Nathalie Perek, Nathalie Le Jeune, et al.
Metal Ions in Life Sciences|February 3, 2018
Copper Complexes in Cancer TherapyDelphine Denoyer, Sharnel A S Clatworthy, Michael A Cater
Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
Study of monoglutathionyl conjugates TC-99M-sestamibi and TC-99M-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cellsNathalie Le Jeune, Nathalie Perek, Delphine Denoyer, et al.
Drug Discovery Today|January 23, 2023
The FDA modernisation act 2.0: Bringing non-animal technologies to the regulatory tableAlastair Stewart, Delphine Denoyer, Xumei Gao, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 26, 2002
Modulation of the multidrug resistance of glioma by glutathione levels depletion--interaction with Tc-99M-Sestamibi and Tc-99M-TetrofosminNathalie Perek, Françoise Koumanov, Delphine Denoyer, et al.
Metallomics : Integrated Biometal Science|August 28, 2015
Targeting copper in cancer therapy: 'Copper That Cancer'Delphine Denoyer, Shashank Masaldan, Sharon La Fontaine, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 25, 2003
The multidrug resistance of in vitro tumor cell lines derived from human breast carcinoma MCF-7 does not influence pentavalent technetium-99m-dimercaptosuccinic Acid uptakeDelphine Denoyer, Nathalie Perek, Nathalie Le Jeune, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Drug Metabolism|March 6, 2002
The multidrug resistance mechanisms and their interactions with the radiopharmaceutical probes used for an in vivo detectionNathalie Perek, Delphine Denoyer
Cancer Biotherapy & Radiopharmaceuticals|August 24, 2005
MRP-1 protein expression and glutathione content of in vitro tumor cell lines derived from human glioma carcinoma U-87-MG do not interact with 99mTc-glucarate uptakeNathalie Perek, Nathalie Le Jeune, Delphine Denoyer, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Influence of glutathione depletion on plasma membrane cholesterol esterification and on Tc-99m-sestamibi and Tc-99m-tetrofosmin uptakes: a comparative study in sensitive U-87-MG and multidrug-resistant MRP1 human glioma cellsNathalie Le Jeune, Nathalie Perek, Delphine Denoyer, et al.
Current Cancer Drug Targets|May 23, 2006
Spectrum of radiopharmaceuticals in nuclear oncologyDelphine Denoyer, Nathalie Perek, Nathalie Le Jeune, et al.
Metal Ions in Life Sciences|February 3, 2018
Copper Complexes in Cancer TherapyDelphine Denoyer, Sharnel A S Clatworthy, Michael A Cater
Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
Study of monoglutathionyl conjugates TC-99M-sestamibi and TC-99M-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cellsNathalie Le Jeune, Nathalie Perek, Delphine Denoyer, et al.
Drug Discovery Today|January 23, 2023
The FDA modernisation act 2.0: Bringing non-animal technologies to the regulatory tableAlastair Stewart, Delphine Denoyer, Xumei Gao, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 26, 2002
Modulation of the multidrug resistance of glioma by glutathione levels depletion--interaction with Tc-99M-Sestamibi and Tc-99M-TetrofosminNathalie Perek, Françoise Koumanov, Delphine Denoyer, et al.
Metallomics : Integrated Biometal Science|August 28, 2015
Targeting copper in cancer therapy: 'Copper That Cancer'Delphine Denoyer, Shashank Masaldan, Sharon La Fontaine, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 25, 2003
The multidrug resistance of in vitro tumor cell lines derived from human breast carcinoma MCF-7 does not influence pentavalent technetium-99m-dimercaptosuccinic Acid uptakeDelphine Denoyer, Nathalie Perek, Nathalie Le Jeune, et al.
Pageof 5